Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- University of A Coruña
- ICN2
- Autonomous University of Madrid (Universidad Autónoma de Madrid)
- Centro de Investigaciones sobre Desertificación (CIDE, CSIC-UV-GVA)
- Fundación Investigación del Cáncer Universidad de Salamanca
- IBIMA Plataforma BIONAND
- IDAEA-CSIC
- IMDEA Networks Institute
- UNIVERSIDAD DE ZARAGOZA
- UNIVERSITAT POMPEU FABRA
- Universitat Politècnica de València
- Universitat de Barcelona
- University of Cantabria
- University of Lleida
- University of Santiago de Compostela
- 6 more »
- « less
-
Field
-
quantify the impact of nonlinearity on flow and transportin confined porous media. We put particular emphasis on three sources of nonlinearity: non-Newtonian rheology, large driving rates leading to dynamic
-
FieldComputer scienceEducation LevelMaster Degree or equivalent Specific Requirements Candidates must meet the requirements to join a PhD programme at UPV during the application period. Candidates must be
-
. fluorescence microscopy, flow cytometry, image analysis or CRISPR/Cas9). Experience with mitochondrial biology, tumour–stromal interactions, extracellular vesicles, intercellular communication or therapy
-
Offer Description The ROMEO project seeks to overcome a major hurdle in nanomedicine: the fact that less than 1% of current nanoparticles reach their target because they are captured by macrophages in
-
interpretation in the context of the current scientific literature. Work will combine extensive in vitro cell culture-based experimentation, including the use of patient-derived samples, with in vivo validation in
-
cells isolated from peripheral blood and cerebrospinal fluid samples. Carry out cellular and molecular biology experiments, including B-cell isolation and culture, flow cytometry and molecular analyses
-
therapy for SMA was nusinersen, an antisense oligonucleotide (ASO) that promotes exon 7 inclusion in SMN2 transcripts, thereby increasing functional SMN protein levels. Although current therapies have
-
. According to the current recruitment timeline, eligibility screening is planned for mid November 2026. The final selection will be communicated shortly after. Recruitment will follow open, transparent, and
-
biomedical research who wish to carry out doctoral studies at VHIR. The aim of these grants is to train 4 doctoral candidates over a period of four years within the research groups of the Vall d'Hebron
-
Unit that offers SBRT treatments for localized tumors and oligometastases in its service portfolio (1 point per year of experience, maximum 2 points). - Completion of a training period at a prestigious